ANISA BULLOCK: Open Payments
NPI 1598235590 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 28 payments from 8 companies in 2025. Trend: 2023 $866 · 2024 $774 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $264 |
| Novartis Pharmaceuticals Corporation | 6 | $113 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Amgen Inc. | 2 | $32 |
| CVRx, Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: WAINUA, LEQVIO, LifeVest, Kerendia, FARXIGA, REPATHA, Barostim Neo System, JARDIANCE.
Industry payments across GA — which companies pay providers there.
